ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim GmbH is closely
ScripLexeo Therapeutics Inc. became the 20th biopharma to launch an initial public offering in the US on 2 November when it sold 9.09 million shares at $11 each to gross $100m in its late-night public mar
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sangamo Partners In Neurology With Lill
ScripAtlas Venture added more fuel to its biotechnology start-up engine with a $450m fund announced on 3 March, which the venture capital firm will invest in new companies developing novel therapeutics and